Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα

Leukemia

Volumn 30, Issue 3, 2016, Pages 674-682

  Bueno, C ^a   Sardina, J L ^b   Di Stefano, B ^b   Romero Moya, D ^a   Munoz Lopez A ^a   Ariza, L ^a   Chillon M C ^c   Balanzategui, A ^c   Castano J ^a   Herreros, A ^d   Fraga, M F ^e   Fernandez A ^e   Granada, I ^a,f   Quintana Bustamante, O ^g   Segovia, J C ^g   Nishimura, K ^h   Ohtaka, M ⁱ   Nakanishi, M ⁱ   Graf, T ^b   Menendez, P ^a,j  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g CIEMAT   (Spain)

^h UNIVERSITY OF TSUKUBA   (Japan)

ⁱ NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^j INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD19 ANTIGEN; CD20 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HEPATOCYTE NUCLEAR FACTOR 3BETA; IMMUNOGLOBULIN; MICROTUBULE ASSOCIATED PROTEIN 2; OCTAMER TRANSCRIPTION FACTOR 4; RNA; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; MYC PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CELL CLONE; CELL FRACTIONATION; CELL ISOLATION; CENTRIFUGATION; COCULTURE; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE REARRANGEMENT; GERM LAYER; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; MOUSE; NEWBORN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSIENT EXPRESSION; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; FETUS BLOOD; GENE EXPRESSION; GENE VECTOR; GENETICS; IMMUNOLOGY; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PRIMARY CELL CULTURE; SENDAI VIRUS; VDJ RECOMBINATION;

B-LYMPHOCYTES; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL SEPARATION; CELLULAR REPROGRAMMING; FETAL BLOOD; GENE EXPRESSION; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MYELOID CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-MYC; SENDAI VIRUS; SOXB1 TRANSCRIPTION FACTORS; V(D)J RECOMBINATION;

EID: 84959324813     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2015.294     Document Type: Article

References (44)

1. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011; 13: 497-505
2. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276-1284
3. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009; 106: 15720-15725
4. Merling RK, Sweeney CL, Choi U, De Ravin SS, Myers TG, Otaizo-Carrasquero F, et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood 2013; 121: e98-107
5. Meng X, Neises A, Su RJ, Payne KJ, Ritter L, Gridley DS, et al. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther 2012; 20: 408-416
6. Ramos-Mejia V, Montes R, Bueno C, Ayllon V, Real PJ, Rodriguez R, et al. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. PLoS One 2012; 7: e35824
7. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113: 5476-5479
8. Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 2013; 31: 458-466
9. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010; 7: 11-14
10. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010; 7: 20-24
11. Barrett R, Ornelas L, Yeager N, Mandefro B, Sahabian A, Lenaeus L, et al. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl Med 2014; 3: 1429-1434
12. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008; 133: 250-264
13. Choi SM, Liu H, Chaudhari P, Kim Y, Cheng L, Feng J, et al. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood 2011; 118: 1801-1805
14. Di Stefano B, Sardina JL, van Oevelen C, Collombet S, Kallin EM, Vicent GP, et al. C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells. Nature 2014; 506: 235-239
15. Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y, et al. Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 2011; 286: 4760-4771
16. Okano S, Yonemitsu Y, Nagata S, Sata S, Onimaru M, Nakagawa K, et al. Recombinant Sendai virus vectors for activated T lymphocytes. Gene Ther 2003; 10: 1381-1391
17. Bueno C, Montes R, Melen GJ, Ramos-Mejia V, Real PJ, Ayllon V, et al A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification. Cell Res 2012; 22: 986-1002
18. Nishimura T, Kaneko S, Kawana-Tachikawa A, Tajima Y, Goto H, Zhu D, et al. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 2013; 12: 114-126
19. Ramos-Mejia V, Fernandez AF, Ayllon V, Real PJ, Bueno C, Anderson P, et al. Maintenance of human embryonic stem cells in mesenchymal stem cellconditioned media augments hematopoietic specification. Stem Cells Dev 2012; 21: 1549-1558
20. Sanchez L, Gutierrez-Aranda I, Ligero G, Martin M, Ayllon V, Real PJ, et al. Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation. Tissue Eng Part C Methods 2012; 18: 387-396
21. Ramos-Mejia V, Munoz-Lopez M, Garcia-Perez JL, Menendez P. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res 2010; 20: 1092-1095
22. Castaño J, Menendez P, Bruzos-Cidon C, Straccia M, Sousa A, Zabaleta L, et al. Fast and efficient neural conversion of human hematopoietic cells. Stem Cell Reports 2014; 3: 1118-1131
23. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodriguez-Piza I, Vassena R, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009; 5: 353-357
24. Catalina P, Montes R, Ligero G, Sanchez L, de la Cueva T, Bueno C, et al. Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?. Mol Cancer 2008; 7: 76
25. Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, Munoz-Lopez M, Real PJ, Macia A, et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 2010; 28: 1568-1570
26. Calvanese V, Horrillo A, Hmadcha A, Suarez-Alvarez B, Fernandez AF, Lara E, et al. Cancer genes hypermethylated in human embryonic stem cells. PLoS One 2008; 3: e3294
27. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317
28. Gonzalez D, Gonzalez M, Balanzategui A, Sarasquete ME, Lopez-Perez R, Chillon MC, et al. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma. Haematologica 2005; 90: 906-913
29. Lopez-Perez R, Garcia-Sanz R, Gonzalez D, Balanzategui A, Chillon MC, Alaejos I, et al. Gene scanning of VDJH-Amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 665-672
30. Ayllon V, Bueno C, Ramos-Mejia V, Navarro-Montero O, Prieto C, Real PJ, et al. The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate. Leukemia 2015; 29: 1741-1753
31. Ramos-Mejia V, Melen GJ, Sanchez L, Gutierrez-Aranda I, Ligero G, Cortes JL, et al. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther 2010; 18: 2173-2181
32. Ramos-Mejia V, Navarro-Montero O, Ayllon V, Bueno C, Romero T, Real PJ, et al. HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood 2014; 124: 3065-3075
33. Real PJ, Ligero G, Ayllon V, Ramos-Mejia V, Bueno C, Gutierrez-Aranda I, et al. SCL/ TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol Ther 2012; 20: 1443-1453
34. Real PJ, Navarro-Montero O, Ramos-Mejia V, Ayllon V, Bueno C, Menendez P. The role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells. Blood 2013; 121: 5250-5252
35. French A, Yang CT, Taylor S, Watt SM, Carpenter L. Human induced pluripotent stem cell-derived B lymphocytes express sIgM and can be generated via a hemogenic endothelium intermediate. Stem Cells Dev 2015; 24: 1082-1095
36. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105: 617-626
37. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402
38. Kisielow P, von Boehmer H. Development and selection of T cells: facts and puzzles. Adv Immunol 1995; 58: 87-209
39. Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-Associated genes. Stem Cells 2010; 28: 713-720
40. Sullivan GJ, Bai Y, Fletcher J, Wilmut I. Induced pluripotent stem cells: epigenetic memories and practical implications. Mol Hum Reprod 2010; 16: 880-885
41. Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011; 21: 518-529
42. Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA, et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009; 139: 573-586
43. Di Tullio A, Vu Manh TP, Schubert A, Castellano G, Mansson R, Graf T. CCAAT/enhancer binding protein alpha (C/EBP(alpha))-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation. Proc Natl Acad Sci USA 2011; 108: 17016-17021
44. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2011; 29: 1117-1119